Medicine Pharmaceutical products Prescription 
World of DTC Marketing
MARCH 10, 2022
market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7
European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s position in the global pharmaceutical packaging and labelling market The authors highlighted that Europe led the worldwide market at 27 percent in 2022. The authors wrote that driving factors include increasing demand for branded drugs, over the counter medicines as well as specialty medicine. percent in 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Contrarian Sales Techniques
NOVEMBER 18, 2024
Imagine getting your medicines delivered right to your doorstep, without stepping out of the house. With platforms like Esyms and DoctorOnCall leading the way, Malaysians can now order prescription and over-the-counter medications online, and have them delivered directly to their homes. Sounds convenient, right? The problem?
pharmaphorum
OCTOBER 27, 2022
However, there is a general prohibition in the legislation of using celebrities to promote medicines. Amos-Stone assists companies on strategic issues arising during the life cycle of pharmaceutical products, including regulatory data protection, supplementary protection certificates, paediatric rewards, and orphan market exclusivity.
Pharmaceutical Technology
FEBRUARY 28, 2023
Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. The company offers generic medicines and biosimilars through Sandoz.
PM360
MAY 23, 2024
For example, Bryan’s leadership played a pivotal role in the design and development of Veeva Compass’ modern data products—Veeva Compass Prescriber and National—featuring prescriber -and national- level projections based on both prescription and medical claims. As rare diseases affect about 1 in 10 people in the U.S.,
European Pharmaceutical Review
APRIL 21, 2023
Giving environmental risk assessments teeth Since 2005, the authorisation of a human pharmaceutical product requires an environmental risk assessment (ERA). Interestingly, this is not the case for veterinary medicines, where the authorisation can actually be refused if the risk is not adequately mitigated.
Expert insights. Personalized for you.
205 
Let's personalize your content